The dipeptide h-trp-glu-oh shows highly antagonistic activity against ppar gamma: bioassay with molecular modeling simulation
文献类型：期刊论文
| 作者 | Ye, F; Zhang, ZS; Luo, HB; Shen, JH; Chen, KX; Shen, X; Jiang, HL |
| 刊名 | Chembiochem
 |
| 出版日期 | 2006 |
| 卷号 | 7期号:1页码:74-82 |
| 关键词 | Antagonists Ligand binding Molecular modeling Ppar Surface plasmon resonance Yeast two-hybrid assay |
| ISSN号 | 1439-4227 |
| DOI | 10.1002/cbic.200500186 |
| 通讯作者 | Shen, x() |
| 英文摘要 | The peroxisome proliferator-activated receptor gamma (ppar gamma) is an important therapeutic drug target for several conditions, including diabetes, inflammation, dyslipidemia, hypertension, and cancer. it is shown that on antagonist or partial agonist of ppar gamma has attractive potential applications in the discovery of novel antidiabetic agents that may retain efficacious insulin-sensitizing properties and minimize potential side effects. in this work, the dipeptide h-trp-glu-oh (g3335) was discovered to be a novel ppar gamma antagonist. biacore 3000 results based on the surface plasmon resonance (spr) technique showed that g3335 exhibits a highly specific binding affinity against ppar gamma (k-d= 8.34 mu m) and is able to block rosiglitazone, a potent ppar gamma agonist, in the stimulation of the interaction between the ppar gamma ligand-binding domain (lbd) and rxr alpha-lbd. yeast two-hybrid assays demonstrated that g3335 exhibits strong antagonistic activity (ic50=8.67 mu m) in perturbing rosiglitazone in the promotion 1 of the ppar gamma-lbd-cbp interaction. moreover, in transactivation assays, g3335 was further confirmed as an antagonist of ppar gamma in that g3335 could competitively bind to ppar gamma against 0.1,mu m rosiglitazone to repress reporter-gene expression with an ic50 value of 31.9 mu m. in addition, homology modeling and molecular-docking analyses were performed to investigate the binding mode of ppar gamma-lbd with g3335 at the atomic level. the results suggested that residues cys285, arg288, ser289, and his449 in ppar gamma ploy vital roles in ppar gamma-lbd-g3335 binding. the significance of cys285 for ppar gamma-lbd-g3335 interaction was further demonstrated by ppar gamma point mutation (ppar gamma-lbd-cys285ala). it is hoped our current work will provide a powerful approach for the discovery of ppar gamma antagonists, and that g3335 might be developed as a possible lead compound in diabetes research. |
| WOS关键词 | ACTIVATED RECEPTOR-GAMMA ; INHIBITS ADIPOCYTE DIFFERENTIATION ; LIGAND-BINDING ; GENE-EXPRESSION ; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) ; ORBITAL ELECTRONEGATIVITY ; INSULIN-RESISTANCE ; ALPHA ; THIAZOLIDINEDIONE ; DISCOVERY |
| WOS研究方向 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy |
| WOS类目 | Biochemistry & Molecular Biology ; Chemistry, Medicinal |
| 语种 | 英语 |
| WOS记录号 | WOS:000234701000013 |
| 出版者 | WILEY-V C H VERLAG GMBH |
| URI标识 | http://www.irgrid.ac.cn/handle/1471x/2379032 |
| 专题 | 中国科学院大学 |
| 通讯作者 | Shen, X |
| 作者单位 | 1.Chinese Acad Sci, Grad Sch, Shanghai Inst Mat Med,State Key Lab Drug Res, Shanghai Inst Biol Sci,Drug Discovery & Design Ct, Shanghai 201203, Peoples R China 2.E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China |
| 推荐引用方式 GB/T 7714 | Ye, F,Zhang, ZS,Luo, HB,et al. The dipeptide h-trp-glu-oh shows highly antagonistic activity against ppar gamma: bioassay with molecular modeling simulation[J]. Chembiochem,2006,7(1):74-82. |
| APA | Ye, F.,Zhang, ZS.,Luo, HB.,Shen, JH.,Chen, KX.,...&Jiang, HL.(2006).The dipeptide h-trp-glu-oh shows highly antagonistic activity against ppar gamma: bioassay with molecular modeling simulation.Chembiochem,7(1),74-82. |
| MLA | Ye, F,et al."The dipeptide h-trp-glu-oh shows highly antagonistic activity against ppar gamma: bioassay with molecular modeling simulation".Chembiochem 7.1(2006):74-82. |
入库方式： iSwitch采集
来源：中国科学院大学
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。